This study evaluates the content uniformity and dissolution characteristics of oral Winstrol (Stanozolol) tablets. Ensuring that each tablet contains a consistent amount of the active ingredient and that it is released effectively in the gastrointestinal tract is fundamental for predictable therapeutic outcomes and patient safety.

GC-MS and General Dissolution Assay: GC-MS was used to accurately measure the Stanozolol content in individual tablets, assessing batch uniformity. The General Dissolution Assay simulated gastric and intestinal conditions to determine the rate and extent of drug release, which is critical for bioavailability.

The analysis of oral Winstrol tablets shows excellent content uniformity, with all tested units meeting the acceptance criteria. The average potency is 8.73 mg/tab, and the purity is 87.3%. The dissolution profile is rapid and complete, indicating good bioavailability. The product demonstrates high manufacturing quality and consistency, making it reliable for oral administration and achieving the desired pharmacological effects.